Clinical Trials Browser

Phase 2 × Maytansine × 90 days × Clear all

NCT04620187 2026-02-24

Post-op T-DM1 in HER-2+ Salivary Gland Carcinomas

Phase 2 Recruiting

Salivary Gland Neoplasms